Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc. filed this Current Report on Form 8-K on March 31, 2026. The filing serves to announce the Company's financial results for the quarter and year ended December 31, 2025. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not disclosed within the body of this Form 8-K.
Material Changes
No material changes versus prior periods are detailed in this document. The filing solely acts as a notification that results for the period ended December 31, 2025, have been issued.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual financial figures for the quarter and year ended December 31, 2025.
- Verify the trading symbol VTAK on the NYSE American exchange.
- Confirm the Company's status as a non-emerging growth company based on the unchecked box in the filing.
- Note that the financial data in this 8-K is not legally "filed" and may require separate verification in the attached exhibit.